NCT02279602 2018-04-17
Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study
Mateon Therapeutics
Phase 2 Completed
Mateon Therapeutics
Mateon Therapeutics
Mateon Therapeutics
Mateon Therapeutics
Case Comprehensive Cancer Center